<DOC>
	<DOCNO>NCT00035321</DOCNO>
	<brief_summary>The purpose study determine : - Whether olanzapine plus fluoxetine combination help patient treatment-resistant major depression . - The safety olanzapine plus fluoxetine combination , plus side effect might associate combination . - The effectiveness olanzapine plus fluoxetine compare olanzapine fluoxetine alone .</brief_summary>
	<brief_title>The Study Olanzapine Plus Fluoxetine Combination Treatment Treatment Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male female patient , 18 65 year age . Each patient must level understanding sufficient perform test examination require protocol , must consider reliable accord investigator 's clinical judgement Patients must fulfill criterion recurrent MDD without psychotic feature define DSMIV , base clinical assessment confirm Structured Clinical Interview DSMIV Axis I Disorders Clinical Version ( SCIDI ) plus Major Depressive Disorder Specifiers include Research Version SCIDI . This include least one follow diagnosis : 296.31 , 296.32 , 296.33 Female patient childbearing potential must use medically accept mean contraception throughout course study . Use oral injectable contraception must initiate prior visit 2 Failure achieve satisfactory antidepressant response adequate trial antidepressant ( except fluoxetine ) , least 6 week acceptable dose great , occur within current episode MDD Treatment drug within last 30 day receive regulatory approval time study entry Exposure OFC Lillysponsored clinical trial investigate OFC , patient historically fail respond olanzapine fluoxetine combination circumstance Persons previously enter Lillysponsored study investigate olanzapine Female patient either pregnant nursing Serious , unstable illness death anticipate within 1 year intensive care unit hospitalization disease anticipate within 6 month . This include hepatic ( specifically degree jaundice ) , renal , gastroenterologic , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease ( specifically current agranulocytosis absolute neutrophil count &lt; 500 mm_3 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>